2024
Evaluation of completeness of commonly used data elements for clinical trial eligibility criteria using a registry-enhanced data collection process: Results from patients with non-small cell lung cancer (NSCLC) and colorectal cancer (CRC) at three community oncology practices.
Campbell Fontaine A, McAneny B, Tucker V, Koontz M, Trotter C, Paulson J, McMurdie P, Tezcan A, Peguero J, Peguero J, Campos L. Evaluation of completeness of commonly used data elements for clinical trial eligibility criteria using a registry-enhanced data collection process: Results from patients with non-small cell lung cancer (NSCLC) and colorectal cancer (CRC) at three community oncology practices. Journal Of Clinical Oncology 2024, 20: 346-346. DOI: 10.1200/op.2024.20.10_suppl.346.Peer-Reviewed Original ResearchNon-small cell lung cancerCommunity oncology practicesColorectal cancerDiagnosis dateOncology practiceCancer diagnosisData elementsEligibility assessmentColorectal cancer patientsCompletion ratesGenomic test resultsEssential data elementsLung cancerClinical trialsRemote staffMale to female ratioSystemic anti-cancer treatmentTrial eligibility criteriaPatient identificationECOG performance statusICD10 codesPatient RegistryYears of ageLung cancer diagnosisCell lung cancer
2023
Combining Low-Dose Computer-Tomography-Based Radiomics and Serum Metabolomics for Diagnosis of Malignant Nodules in Participants of Lung Cancer Screening Studies
Zyla J, Marczyk M, Prazuch W, Sitkiewicz M, Durawa A, Jelitto M, Dziadziuszko K, Jelonek K, Kurczyk A, Szurowska E, Rzyman W, Widłak P, Polanska J. Combining Low-Dose Computer-Tomography-Based Radiomics and Serum Metabolomics for Diagnosis of Malignant Nodules in Participants of Lung Cancer Screening Studies. Biomolecules 2023, 14: 44. PMID: 38254644, PMCID: PMC10813699, DOI: 10.3390/biom14010044.Peer-Reviewed Original ResearchSerum metabolomicsComputed tomography lung cancer screeningLow-dose computed tomography (LDCT) lung cancer screeningLung cancer screening studyTomography lung cancer screeningLung cancer screeningCancer screening studyLung cancer diagnosisCollected cohortCancer screeningLung cancerSerum metabolomeBenign lesionsPulmonary nodulesMetabolomic evaluationAuxiliary biomarkerLogistic regressionDiagnosisCancer diagnosisLung nodulesMalignant nodulesScreening studyPatientsRadiomicsMolecular featuresImpact of the COVID-19 Pandemic on Lung Cancer Screening Processes in a Northeast Tertiary Health Care Network
Udelsman B, Detterbeck F, Tanoue L, Mase V, Boffa D, Blasberg J, Dhanasopon A, Ely S, Mazzarelli L, Bader A, Woodard G. Impact of the COVID-19 Pandemic on Lung Cancer Screening Processes in a Northeast Tertiary Health Care Network. Journal Of Computer Assisted Tomography 2023, 48: 222-225. PMID: 37832536, DOI: 10.1097/rct.0000000000001549.Peer-Reviewed Original ResearchHealth care networkLung cancer screening processLung cancer screening programsCare networkCancer screening programsCoronavirus disease 2019 (COVID-19) pandemicComputed tomography scanCOVID-19 hospitalizationCOVID-19 surgeCancer screening processDisease 2019 pandemicLung cancer diagnosisHealth care systemAverage hospitalizationRadiology databaseLung cancerTomography scanScreening programCare systemCancer diagnosisMonthsHospitalizationCOVID-19COVID-19 pandemicPandemic
2021
OTHR-11. Comprehensive Analysis of Driver Mutation Profile in a Cohort of Lung Cancer Patients Using Targeted Gene Panel Analysis with Focus on Brain Metastatic Disease
Kazarian M, Cui J, Tocino I, Mahajan A, Aboian M. OTHR-11. Comprehensive Analysis of Driver Mutation Profile in a Cohort of Lung Cancer Patients Using Targeted Gene Panel Analysis with Focus on Brain Metastatic Disease. Neuro-Oncology Advances 2021, 3: iii16-iii16. PMCID: PMC8351181, DOI: 10.1093/noajnl/vdab071.066.Peer-Reviewed Original ResearchNon-small cell lung cancerBrain metastasesDeep white matterLung cancerGene panel analysisWhite matterLung cancer brain metastasesHospital tumor registryTertiary referral institutionCancer brain metastasesProportion of patientsBrain metastatic diseaseMajority of patientsBrain metastatic lesionsCell lung cancerLung cancer patientsLung cancer cohortTargeted Gene Panel AnalysisLung cancer diagnosisMolecular signaturesNext-generation sequencing resultsMetastatic diseasePatient demographicsTumor RegistryMetastatic lesionsConsidering lead-time bias in evaluating the effectiveness of lung cancer screening with real-world data
Yang SC, Wang JD, Wang SY. Considering lead-time bias in evaluating the effectiveness of lung cancer screening with real-world data. Scientific Reports 2021, 11: 12180. PMID: 34108586, PMCID: PMC8190256, DOI: 10.1038/s41598-021-91852-6.Peer-Reviewed Original ResearchConceptsLead-time biasNational Lung Screening TrialStage shiftStage IALife expectancyCancer patientsLung cancerCalendar yearNationwide cancer registryBenefits of screeningLung cancer patientsReal-world studyLung cancer diagnosisMean life expectancyTomography screeningCancer RegistryLE gainsCancer screeningEarly diagnosisScreening TrialGeneral populationSame pathologyYounger agePathologyCancer diagnosis
2018
EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes
Marcoux N, Gettinger SN, O’Kane G, Arbour KC, Neal JW, Husain H, Evans TL, Brahmer JR, Muzikansky A, Bonomi PD, del Prete S, Wurtz A, Farago AF, Dias-Santagata D, Mino-Kenudson M, Reckamp KL, Yu HA, Wakelee HA, Shepherd FA, Piotrowska Z, Sequist LV. EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes. Journal Of Clinical Oncology 2018, 37: 278-285. PMID: 30550363, PMCID: PMC7001776, DOI: 10.1200/jco.18.01585.Peer-Reviewed Original ResearchMeSH KeywordsAdenocarcinoma of LungAdultAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsBiomarkers, TumorCarcinoma, Non-Small-Cell LungClass I Phosphatidylinositol 3-KinasesErbB ReceptorsFemaleGenetic Predisposition to DiseaseHumansLung NeoplasmsMaleMiddle AgedMutationNeoplasm GradingNorth AmericaPhenotypeRetinoblastoma Binding ProteinsRetrospective StudiesSmall Cell Lung CarcinomaTime FactorsTreatment OutcomeTumor Suppressor Protein p53Ubiquitin-Protein LigasesConceptsNon-small cell lung cancerSmall cell lung cancerEGFR-mutant non-small cell lung cancerSCLC transformationLung cancerNeuroendocrine carcinomaEGFR mutationsDe novo small cell lung cancersInitial lung cancer diagnosisHigh-grade neuroendocrine carcinomaEGFR tyrosine kinase inhibitorsT790M positivityMedian overall survivalCell lung cancerTyrosine kinase inhibitorsHigh response rateEGFR-mutant adenocarcinomaLung cancer diagnosisCNS metastasesCheckpoint inhibitorsMedian survivalOverall survivalClinical courseMixed histologyClinical outcomesReduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at Diagnosis
Grover S, Desir F, Jing Y, Bhatia RK, Trifiletti DM, Swisher-McClure S, Kobie J, Moore RD, Rabkin CS, Silverberg MJ, Salters K, Mathews WC, Gill MJ, Thorne JE, Castilho J, Kitahata MM, Justice A, Horberg MA, Achenbach CJ, Mayor AM, Althoff KN. Reduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at Diagnosis. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2018, 79: 421-429. PMID: 30211722, PMCID: PMC6203623, DOI: 10.1097/qai.0000000000001842.Peer-Reviewed Original ResearchConceptsLung cancer diagnosisCancer diagnosisLung cancerCancer stageNorth American AIDS Cohort CollaborationAdjusted mortality rate ratioHodgkin lymphoma diagnosisOnly lung cancerRole of HIVRisk of deathMortality rate ratiosCohort CollaborationImmune dysfunctionCervical cancerImmune suppressionCancer outcomesSignificant immunosuppressionCancer survivalPoor survivalLymphoma diagnosisMortality rateProbability of survivalPWHHigh mortalityCancer
2017
HIV Infection, Immunosuppression, and Age at Diagnosis of Non-AIDS-Defining Cancers
Shiels MS, Althoff KN, Pfeiffer RM, Achenbach CJ, Abraham AG, Castilho J, Cescon A, D’Souza G, Dubrow R, Eron JJ, Gebo K, Gill M, Goedert JJ, Grover S, Hessol NA, Justice A, Kitahata M, Mayor A, Moore RD, Napravnik S, Novak RM, Thorne JE, Silverberg MJ, Engels EA, AIDS F. HIV Infection, Immunosuppression, and Age at Diagnosis of Non-AIDS-Defining Cancers. Clinical Infectious Diseases 2017, 64: 468-475. PMID: 27940936, PMCID: PMC5850313, DOI: 10.1093/cid/ciw764.Peer-Reviewed Original ResearchConceptsOral cavity/pharynxYounger ageCancer diagnosisCD4 countMedian ageLung cancerKidney cancerGeneral populationNorth American AIDS Cohort CollaborationMost cancersEnd Results ProgramHuman immunodeficiency virusRisk factor exposureLung cancer diagnosisAccelerated cancer progressionCohort CollaborationNon-AIDSAnal cancerHIV infectionImmunodeficiency virusResults ProgramMyeloma diagnosisPLWHAIDS statusCancer
2016
A Cohort Study of Mortality in Individuals With and Without Schizophrenia After Diagnosis of Lung Cancer.
Bradford DW, Goulet J, Hunt M, Cunningham NC, Hoff R. A Cohort Study of Mortality in Individuals With and Without Schizophrenia After Diagnosis of Lung Cancer. The Journal Of Clinical Psychiatry 2016, 77: e1626-e1630. PMID: 27780332, DOI: 10.4088/jcp.15m10281.Peer-Reviewed Original ResearchConceptsSerious mental illnessLung cancerMental illnessVeterans Affairs systemCause of deathSubstance use disordersLung cancer diagnosisCause mortalityCohort studyHazard ratioSmoking statusCommon malignancyCancer careLeading causePoor survivalHigh riskUse disordersSurvival analysisCancerMortalityIllnessSchizophreniaDiagnosisCancer diagnosisPotential disparities
2015
SVM Based Lung Cancer Diagnosis Using Multiple Image Features in PET/CT
Guo N, Yen R, Fakhri G, Li Q. SVM Based Lung Cancer Diagnosis Using Multiple Image Features in PET/CT. 2015, 1-4. DOI: 10.1109/nssmic.2015.7582234.Peer-Reviewed Original ResearchIntra-tumor heterogeneityLung cancer diagnosisF-FLTCT textureStage malignancyLung cancerStaging of lung cancerCT texture featuresAdvanced stage malignanciesEarly stage malignancyImprove tumor stagingCancer diagnosisImage featuresPET/CT scansPET/CT imagingTumor stageTumor heterogeneityCancer stageDiagnostic accuracyPatient groupClinical valuePET/CTGold standardLung nodulesPET imaging
2013
Prognostic Factors in Patients With Brain Metastases at Initial Non-Small Cell Lung Cancer Diagnosis
Rutter C, Mancini B, Yu J, Chiang V, Bindra R. Prognostic Factors in Patients With Brain Metastases at Initial Non-Small Cell Lung Cancer Diagnosis. International Journal Of Radiation Oncology • Biology • Physics 2013, 87: s273. DOI: 10.1016/j.ijrobp.2013.06.711.Peer-Reviewed Original ResearchClinical and Organizational Factors in the Initial Evaluation of Patients With Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Ost DE, Yeung SC, Tanoue LT, Gould MK. Clinical and Organizational Factors in the Initial Evaluation of Patients With Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. CHEST Journal 2013, 143: e121s-e141s. PMID: 23649435, PMCID: PMC4694609, DOI: 10.1378/chest.12-2352.Peer-Reviewed Original ResearchConceptsPulmonary function testsParaneoplastic syndromeLung cancerInitial evaluationDistant metastasisFunction testsPhysical examinationThorough historyAmerican CollegeChest Physicians Evidence-Based Clinical Practice GuidelinesEvidence-based clinical practice guidelinesMultidisciplinary teamCancer treatmentCT imagingDefinitive cancer treatmentClinical practice guidelinesTimeliness of careCurrent medical literatureBasic laboratory testsLung cancer diagnosisGuidelines Oversight CommitteeHealth care qualityEvidence-based approachMultimodality therapyChest PhysiciansThe Stage Classification of Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Detterbeck FC, Postmus PE, Tanoue LT. The Stage Classification of Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. CHEST Journal 2013, 143: e191s-e210s. PMID: 23649438, DOI: 10.1378/chest.12-2354.Peer-Reviewed Original ResearchConceptsChest Physicians Evidence-Based Clinical Practice GuidelinesEvidence-based clinical practice guidelinesClinical practice guidelinesLung cancer diagnosisLung cancerTNM descriptorsPractice guidelinesAmerican CollegeSeventh editionCancer diagnosisStage classification systemClassification systemStage classificationCancerDiagnosisScreening for Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB. Screening for Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. CHEST Journal 2013, 143: e78s-e92s. PMID: 23649455, PMCID: PMC3749713, DOI: 10.1378/chest.12-2350.Peer-Reviewed Original ResearchConceptsLung cancer deathsLung cancerCancer deathChest Physicians Evidence-Based Clinical Practice GuidelinesEvidence-based clinical practice guidelinesLow-dose CT screeningMajority of patientsRisk of complicationsClinical practice guidelinesLung cancer diagnosisSignificant reductionNumber of deathsLDCT screeningCurative treatmentLarge RCTsCT screeningTreatment recommendationsChest radiographsPractice guidelinesAmerican CollegeEffective treatmentElevated riskResult of screeningAdvanced stageSystematic reviewTreatment of Stage III Non-small Cell Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Ramnath N, Dilling TJ, Harris LJ, Kim AW, Michaud GC, Balekian AA, Diekemper R, Detterbeck FC, Arenberg DA. Treatment of Stage III Non-small Cell Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. CHEST Journal 2013, 143: e314s-e340s. PMID: 23649445, DOI: 10.1378/chest.12-2360.Peer-Reviewed Original ResearchConceptsNon-small cell lung cancerLung cancerDefinitive chemoradiationNeoadjuvant therapyStage IIIARandomized trialsPractice guidelinesAmerican CollegeChest Physicians Evidence-Based Clinical Practice GuidelinesEvidence-based clinical practice guidelinesNon-small cell lung cancer diagnosisLow perioperative mortality ratePlatinum-based adjuvant chemotherapyStage IIIA lung cancerStage III lung cancerCell lung cancer diagnosisIIIA lung cancerMicroscopic nodal metastasesProphylactic cranial radiationChest Physicians guidelinesPerioperative mortality rateCell lung cancerClinical practice guidelinesStrength of recommendationsLung cancer diagnosis
2011
Lung Cancer in Older Patients
Gettinger S, Tanoue L. Lung Cancer in Older Patients. Respiratory Medicine 2011, 89-109. DOI: 10.1007/978-1-60761-727-3_5.Peer-Reviewed Original ResearchYears of ageLung cancerOlder patientsBest supportive careMajority of patientsCancer-related mortalityStandard of careNovel therapeutic approachesLung cancer diagnosisAdvanced diseaseElderly patientsSupportive careMedian ageClinical trialsClinical studiesAggressive approachTherapeutic approachesPatientsCancerOlder populationYounger counterpartsCancer diagnosisAgeMortalityDisease
2009
Persistent Smoking After a Diagnosis of Lung Cancer Is Associated With Higher Reported Pain Levels
Daniel M, Keefe FJ, Lyna P, Peterson B, Garst J, Kelley M, Bepler G, Bastian LA. Persistent Smoking After a Diagnosis of Lung Cancer Is Associated With Higher Reported Pain Levels. Journal Of Pain 2009, 10: 323-328. PMID: 19254679, PMCID: PMC2684817, DOI: 10.1016/j.jpain.2008.10.006.Peer-Reviewed Original ResearchConceptsUsual pain levelsPersistent smokersLung cancerPain levelsLogistic regression analysisSevere painFormer smokersPersistent smokingSmoking statusUsual painDisease progressionNicotine intakeLate-stage lung cancerMean pain scoreLung cancer symptomsQuality of lifeRegression analysisLung cancer diagnosisPain scoresAdvanced cancerSmoking cessationMean ageCancer symptomsPainSmokers
2008
Lung Cancer: Evolving Concepts
Silvestri G, Tanoue L. Lung Cancer: Evolving Concepts. Seminars In Respiratory And Critical Care Medicine 2008, 29: 221-222. PMID: 18506659, DOI: 10.1055/s-2008-1076741.Peer-Reviewed Original ResearchConceptsNon-small cell lung cancerCause of morbidityLung cancerPositron emission tomographyIssue of SeminarsSurgical resectionCancer deathCT scanningLung cancer death ratesEarly-stage lung cancerDeath rateNew bronchoscopic techniqueStage IA diseaseCell lung cancerCommon radiographic findingLung cancer mortalityLung cancer screeningTreatment of patientsLung cancer casesCancer death ratesCombination of chemotherapyCritical care medicineSmall pulmonary nodulesLung cancer diagnosisAdult American population
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply